Anaptysbio, Inc
ANAB
Revenue
10.97M
▲3.79M▲52.82%
3 Months ChangeAssets
427.38M
▲21.54M▲5.31%
3 Months ChangeLiabilities
417.50M
▲59.44M▲16.60%
3 Months ChangeFree Cash Flow
-37.28M
▼-12.54M▼-50.67%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-14
Form 8-K
ID: 0001193125-24-200684
2024-08-05
Form 10-Q
ID: 0001370053-24-000041
2024-08-05
Form 8-K
ID: 0001370053-24-000039
2024-06-12
Form 8-K
ID: 0001370053-24-000029
2024-05-09
Form 10-Q
ID: 0001370053-24-000027
2024-05-09
Form 8-K
ID: 0001370053-24-000026
2024-03-11
Form 8-K
ID: 0001370053-24-000010
2024-01-05
Form 8-K
ID: 0001370053-24-000003
2023-11-27
Form 8-K
ID: 0001370053-23-000069
2023-11-02
Form 10-Q
ID: 0001370053-23-000065